GLP‑1 drugs like Ozempic may lower the risk of addiction: New study
A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction—and help people who already have one, a new study shows.
Mar 5, 2026
0
0
Pharmacologic Actions: News and Research on Sodium-Glucose Transporter 2 Inhibitors
MeSH tree: D27.505.696.422.750
GLP-1 medications get at the heart of addiction, study finds
Researchers at Washington University School of Medicine in St. Louis have shown in a new study that GLP-1 medications may be effective at treating and preventing substance-use disorders across all major addictive substances ...
Mar 4, 2026
0
1
Patient data show diabetes medicine could save thousands more lives a year
Diabetes drugs that may soon be prescribed more widely in England could save thousands of lives each year, suggests a new study led by researchers at the London School of Hygiene & Tropical Medicine (LSHTM) and UCL. Using ...
Feb 10, 2026
0
0
Diabetes drug may slow kidney aging, study in fast-aging fish finds
A group of medications often used to treat diabetes may also help protect aging kidneys, according to a new study.
Feb 7, 2026
0
1
Use of glucose-lowering SGLT2i drugs may help patients with gout and diabetes take fewer medications
Gout, a type of inflammatory arthritis caused by a buildup of uric acid (urate) in the body, affects 5.1% of U.S. adults (over 12 million), including 10% of those aged 65 or older. Urate is produced by the body when breaking ...
Feb 3, 2026
0
0
A fish that grows old in months reveals how kidneys age—and how a common drug protects them
In a new study published in Kidney International, researchers report that drugs known as SGLT2 inhibitors prevented age-related deterioration of kidney structure and function in the African turquoise killifish, a vertebrate ...
Jan 26, 2026
0
0
For diabetic patients, novel angiography FFR imaging with glucose-lowering drug effectively protects the heart
A study led by the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), in collaboration with the University of Hong Kong–Shenzhen Hospital, has demonstrated ...
Jan 20, 2026
0
0
SGLT-2 inhibitors linked to lower risk of diabetic foot nerve damage
A large population-based study found that adults with type 2 diabetes (T2D) who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors have a slightly lower risk of developing diabetic foot problems compared ...
Jan 5, 2026
0
0
GLP-1 drugs might help quell sleep apnea, study suggests
A good night's sleep might be an additional benefit some gain from taking weight-loss drugs like Ozempic and Zepbound, a new study says.
Jan 5, 2026
0
5
New test could help enhance decision-making in treatment of chronic kidney disease in type 2 diabetics
Proteomics International Laboratories Ltd (ASX: PIQ) has announced the publication of a peer-reviewed Australian clinical utility study demonstrating that the PromarkerD blood test provides actionable information that significantly ...
Dec 22, 2025
0
0
